SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-094919
Filing Date
2024-08-09
Accepted
2024-08-09 18:00:03
Documents
2
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1539
2 EX-24 cgem-ex24.htm EX-24 13159
  Complete submission text file 0000950170-24-094919.txt   16431
Mailing Address C/O VIACELL, INC. 245 FIRST STREET CAMBRIDGE MA 02142
Business Address
Thistle Mary (Reporting) CIK: 0001317917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39856 | Film No.: 241194217

Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)